|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007634,
umls-concept:C0030705,
umls-concept:C0045093,
umls-concept:C0078257,
umls-concept:C0087111,
umls-concept:C0205179,
umls-concept:C0246415,
umls-concept:C0282460,
umls-concept:C0332174,
umls-concept:C0684249,
umls-concept:C1516224
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2001-12-17
|
|
pubmed:abstractText |
The current study was conducted to evaluate the feasibility, toxicity, and efficacy of weekly docetaxel when paired with either gemcitabine or vinorelbine as the second-line treatment of patients with advanced nonsmall cell lung carcinoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2001 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
92
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2391-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11745295-Adult,
pubmed-meshheading:11745295-Aged,
pubmed-meshheading:11745295-Aged, 80 and over,
pubmed-meshheading:11745295-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11745295-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:11745295-Deoxycytidine,
pubmed-meshheading:11745295-Drug Administration Schedule,
pubmed-meshheading:11745295-Female,
pubmed-meshheading:11745295-Fever,
pubmed-meshheading:11745295-Humans,
pubmed-meshheading:11745295-Infusions, Intravenous,
pubmed-meshheading:11745295-Leukopenia,
pubmed-meshheading:11745295-Lung Neoplasms,
pubmed-meshheading:11745295-Male,
pubmed-meshheading:11745295-Middle Aged,
pubmed-meshheading:11745295-Neutropenia,
pubmed-meshheading:11745295-Paclitaxel,
pubmed-meshheading:11745295-Survival Analysis,
pubmed-meshheading:11745295-Taxoids,
pubmed-meshheading:11745295-Treatment Outcome,
pubmed-meshheading:11745295-Vinblastine
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.
|
|
pubmed:affiliation |
Sarah Cannon Cancer Center, 250 25th Avenue North, Nashville, TN 37203, USA. jhainsworth@tnonc.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
